Cerulean Pharma is a private biopharmaceutical company focused on the development
of novel, nanotechnology-based therapeutics in the areas of oncology, cardiovascular,
autoimmune and inflammatory diseases.
Cerulean is pursuing three key strategies to achieve leadership in Nanopharmaceuticals:
Cerulean has assembled a world-class management team, board of directors and
scientific advisory board that collectively have a significant track record
of business building, product development and scientific breakthroughs. Cerulean
was founded in 2006 and is located in Cambridge, Massachusetts.
Cerulean's Lead Candidate Presented in Talk on Nanoparticle Delivery at ASCO Annual Meeting
Cerulean’s CRLX101 Nanopharmaceutical Phase 2 Clinical Trial Achieves Primary Endpoint
Translational Data on Cerulean’s CRLX101 Polymeric Nanoparticle Candidate Published in PNAS
Cerulean Pharma to Discuss Pre-Clinical and Clinical Results of Nanopharmaceutical CRLX101 at AACR Meeting
Cerulean Pharma to Showcase Nanopharmaceutical Platform at Nanotechnology Innovation Summit
Cerulean to Present on Nanopharmaceutical Platform at Two Major European Conferences
Dr. Fetzer to Highlight Nanopharmaceutical Advancement at BioPharm America Event
Ping Wang, Ph.D.
We speak with researchers behind the latest advancement in graphene hBN research that could boost the development of next-generation electronic and quantum devices.
Dr. Laurene Tetard
AZoNano speaks with Dr. Laurene Tetard from the University of Central Florida about her upcoming research into the development of nanotechnology that can detect animal-borne diseases. The hope is that such technology can be used to help rapidly control infected mosquito populations to protect public
Dr. Amir Sheikhi
AZoNano speaks with Dr. Amir Sheikhi from Pennsylvania State University about his research into creating a new group of nanomaterials designed to capture chemotherapy drugs before they impact healthy tissue, amending a fault traditionally associated with conventional nanoparticles.
The Filmetrics R54 advanced sheet resistance mapping tool for semiconductor and compound semiconductor wafers.
This product profile describes the latest nano-particle analyzer "thesis particle size analyzer" and its key
The Filmetrics F40 turns your benchtop microscope into an instrument for measuring thickness and refractive index.